Target intelligence / Profile preview

Mesobuthus tamulus venom neurotoxins (BT-toxins)

Target
BT-toxins
Molecular classification
Peptide, Neurotoxin, Ion channel modulator
01

Overview

Mesobuthus tamulus venom neurotoxins are a potent collection of bioactive peptides derived from the Indian Red Scorpion, recognized as one of the most medically significant scorpion species globally. These neurotoxins primarily act by modulating voltage-gated ion channels, specifically targeting sodium (Nav) and potassium (Kv) channels in excitable tissues. By delaying the inactivation of sodium channels and blocking potassium channels, the toxins induce prolonged depolarization and repetitive firing of nerve fibers. This physiological disruption leads to a massive, life-threatening release of endogenous catecholamines, often referred to as an autonomic storm, which manifests as severe cardiovascular distress, pulmonary edema, and metabolic disturbances. In clinical practice, these toxins are the primary targets for specific antivenom therapy, which aims to neutralize the venom components before they bind to their respective ion channel targets. Beyond their role in envenomation, specific components like iberiotoxin and tamapin are utilized as high-affinity pharmacological probes in ion channel research and serve as templates for the development of novel therapeutics for autoimmune and neurological conditions.

Other names
Indian Red Scorpion neurotoxinsHottentotta tamulus toxinsMesobuthus tamulus toxinsButhus tamulus venom peptides
02

Mechanism of action

Neutralization of circulating toxins by specific antibodies (antivenom) to prevent binding to physiological targets; pharmacological antagonism of toxin-induced catecholamine release effects using alpha-1 adrenoceptor blockers.

03

Biological functions

Ion channel inhibitionModulation of action potentialNeurotransmitter release enhancementSodium channel inactivation delayPotassium channel blockade
04

Disease associations

Scorpion envenomationAutonomic stormMyocardial infarctionPulmonary edemaHypertension
05

Safety considerations

Anaphylaxis to equine-derived antivenomSerum sicknessRapid clinical deterioration following envenomationHigh potency of toxins leading to multi-organ failure
06

Interacting drugs

Mesobuthus tamulus antivenom

1 more in the full profile.

07

Biomarkers

Serum venom antigen levelsBlood glucose (hyperglycemia)Creatine kinase-MB (CK-MB)Cardiac troponin IElectrocardiogram (ECG) ST-segment changes

Beyond the preview

Go deeper on Mesobuthus tamulus venom neurotoxins (BT-toxins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesobuthus tamulus venom neurotoxins (BT-toxins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call